[EN] ANTIBODY DRUG CONJUGATES<br/>[FR] CONJUGUÉS ANTICORPS-MÉDICAMENT
申请人:NOVARTIS AG
公开号:WO2016203432A1
公开(公告)日:2016-12-22
This application discloses anti-P-cadherin antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments, particularly antibody drug conjugates comprising anti-P-cadherin antibodies conjugated to auristatin analogs. The invention also relates to methods of treating cancer using the antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.
[EN] CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF<br/>[FR] PEPTIDES CYTOTOXIQUES ET LEURS CONJUGUÉS
申请人:IRM LLC
公开号:WO2015095301A3
公开(公告)日:2015-09-03
Compositions and Methods for Treatment of Renin-Angiotensin Aldosterone System (RAAS)- Related Disorders
申请人:Rajagopal Desikan
公开号:US20110257130A1
公开(公告)日:2011-10-20
Compounds are provided which can be useful in reducing the activity of an angiotensin-converting enzyme and thus be used to treat or prevent a renin-angiotensin aldosterone system-related disorder. These compounds include lipoic acid derivatives such as prolyl lipoic acid and pipecolinyl lipoic acid, and other compounds, and these compounds are useful in treating hypertension, stroke, or other renin-angiotensin aldosterone system-related disorders in human or animal patients. Pharmaceutical compositions prepared using these compounds and methods of treatment using these compounds are also provided.
CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF
申请人:GEIERSTANGER Bernhard Hubert
公开号:US20160311853A1
公开(公告)日:2016-10-27
Disclosed herein are novel cytotoxic peptides of formula (I) as described herein:
and the use of such peptides in making immunoconjugates (i.e Antibody Drug Conjugates) Also described herein are immunoconjugates (i.e Antibody Drug Conjugates) comprising such novel cytotoxic peptide linked to an antigen binding moiety, such as an antibody; where such immunoconjugates are useful for treating cell proliferative disorders. The invention further provides pharmaceutical compositions comprising these immunoconjugates, compositions comprising the immunoconjugates with a therapeutic co-agent, and methods to use these immunoconjugates and compositions for treating cell proliferation disorders.